KBKyle B. Bills

Kyle B. Bills

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kyle B. Bills has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anesthesia and Pain Management in Conflict-Affected Regions: A Narrative Review of Barriers and Strategies for Improving Surgical Care

    by Naeel Uddin, Marwa Hamdam, Maria Easler, Chandu Goli, Ayanda C. Mkhize, Lauren Draper, Sierra Brown, Kyle B. Bills

    Background/Objectives: Safe anesthesia and effective pain management in conflict-affected regions are limited by violence, damaged infrastructure, disrupted supply chains, medication and equipment shortages, and loss of trained personnel. This narrative review examines major barriers to perioperative care and practical strategies that may improve access and safety. Methods: A structured literature search evaluated peer-reviewed studies, global health reports, and humanitarian publications, primarily from January 2015 through September 2025, with older foundational clinical sources included when directly relevant to specific anesthesia techniques. Results: Major barriers included shortages of essential anesthetic medications and trained providers, damaged healthcare infrastructure, limited monitoring and oxygen availability, and disrupted supply chains. Reported strategies included ketamine-based anesthesia, regional anesthesia, portable oxygen and anesthesia technologies, telemedicine, and task-sharing models supported by training and local health-system capacity. Obstetric, neonatal, and pediatric patients may face additional risks when appropriately sized equipment, blood products, monitoring, and specialist support are limited. Conclusions: Improving anesthesia and pain management in conflict settings requires adaptable clinical strategies, workforce training, reliable access to essential medications and equipment, and partnerships that strengthen local capacity. Evidence remains heterogeneous, and more conflict-specific outcome data are needed.


  • Open Access

    Glucose Dysregulation as a Driver of Autoimmune Mimicry, Inflammation, and Psychiatric Symptoms: A Narrative Review

    by Jacob Warner-Palacio, Hannah Hunsaker, Amanda McKenna, Brigita Budginas, Levi Fridriksson, Alexander Tam, Christina Nelson, David Sant, Kyle B. Bills

    Background: Glycemic control influences a wide range of psychiatric and physiological symptoms. Many psychiatric conditions are linked to poor glucose regulation. Anti-nuclear antibodies (ANAs), widely used to screen for autoimmune disease, may sometimes reflect transient metabolic immune activation rather than chronic pathology. Evidence suggests that glucose dysregulation, including glycemic variability, reactive hypoglycemia, and postprandial spikes, can trigger systemic inflammation, neuropsychiatric symptoms, and temporary autoantibody production. This review explores how these metabolic phenomena complicate diagnosis and may contribute to misclassification or overtreatment. Methods: We conducted a narrative literature review prioritizing studies on immune activation, psychiatric outcomes, metabolic measures (including continuous glucose monitoring), and therapeutic interventions. Articles from the last ten years were emphasized, with older foundational studies included when relevant. Results: Metabolic instability drives immune dysregulation through macrophage polarization, mitochondrial dysfunction, oxidative stress, and impaired clearance of apoptotic debris. Glycemic variability correlates with increased inflammatory cytokines, autonomic dysfunction, and psychiatric symptoms such as anxiety, depression, and cognitive impairment. Emerging evidence from small studies suggests that correcting glucose abnormalities may reduce metabolic dysfunction and improve neuropsychiatric symptoms. Conclusions: Recognizing glucose dysregulation as a contributor to autoimmune-like and psychiatric symptoms may refine diagnostic and therapeutic approaches. Incorporating a dynamic holistic approach, which in practice includes metabolic assessments, dietary interventions, use of continuous glucose monitoring, and history of blood sugar instability, into rheumatologic and psychiatric evaluations could improve diagnostic precision, reduce unnecessary immunosuppression, and enhance patient outcomes.


  • Open Access

    Glucose dysregulation and glycemic phenotyping in chronic migraine

    by Christina A. Nelson, Kyle W. Reavely, Matthew R. Jennings, Brandon J. Burger, Alexander C. Kim, David W. Sant, Kyle B. Bills

    Background: Emerging evidence suggests that a metabolic mismatch between cerebral energy demand and supply may be a contributing factor to the onset of migraine. Studies have drawn connections between migraine and conditions such as hypoglycemia, fasting, GLUT1 transporter deficiency, insulin resistance, and diabetes, highlighting the role of metabolic dysregulation in migraine susceptibility. Understanding these metabolic patterns could pave the way for personalized migraine treatments targeting glucose regulation. Methods: We conducted a retrospective cohort analysis of chronic migraine subjects (>15 headache days/month) using continuous glucose monitoring (CGM; n = 131) and oral glucose tolerance tests (GTTs; n = 247). Continuous glucose monitoring data were analyzed from a prospective cohort of 24 healthy controls using metrics such as inter/intraday standard deviation (SD), average daily risk range (ADRR), mean amplitude of glycemic excursion (MAGE), mean glucose excursion (MGE), mean of daily differences (MODDs), continuous overall net glycemic action (CONGA24), post-prandial glucose recovery time (PGRT), and post-prandial area under the curve (PP-AUC). Subjects were clustered into three groups based on OGTT responses using K-means clustering to identify possible postprandial phenotypes. Results: Compared to age- and gender-matched standards of normal GTT response, individuals with chronic migraine had significantly lower glucose values at fasting and 2 h. CGM data further revealed that migraine subjects exhibited greater glucose variability, including increased day-to-day (MODDs) and within-day (CONGA24) glycemic variability, and higher interday and intraday standard deviation during waking hours. Post-prandial dysregulation was also observed in measures of MAGE, MGE, PGRT, and PPAUC, with all metrics except PGRT differing significantly from controls during waking hours. Clustering of glucose tolerance test results identified three distinct phenotypes, each characterized by unique glucose and insulin response profiles. Discussion: Chronic migraine subjects exhibited postprandial glucose dysregulation and greater glycemic variability than healthy controls. The identified GTT phenotypes reveal distinct glucose regulation patterns, suggesting the existence of different migraine-associated metabolic profiles. Future research will investigate factors contributing to these phenotypes and their implications for migraine pathogenesis. These findings support the potential for developing targeted migraine treatments informed by glucose dysregulation patterns.